CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

BCBS North Dakota

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
A
Index (ASP = 100)
107.3
Vs. acquisition
+4.4%
Brand index
107.3
Biosimilar index
107.0
Contract variability
High
Drugs observed
909
States
3

Contracts above the typical acquisition benchmark (102.7) on the median drug.

Thin book — treat these figures as indicative, not comparable.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.